Monthly Archives: 二月 2014

Dr. 李淑貞 演講 – 03/05 (三) 14:30 心理 N100

[2014/02/27] 講題:Cognitive and Motivational Development across the Lifespan: Interplays between Neuronal and Contextual Processes

外賓:Dr. 李淑貞 (Dresden University of Technology)

時間:2014/03/05, 14:30 am

地點:心理 N100

摘要:Behavioral, cognitive, and motivational development entails co-constructive interactions between the environmental and social influences from the developmental context, on the one hand, and the individual’s neurobiological inheritance, on the other hand. Key brain networks underlying cognition, emotion, and motivation are innervated by major transmitter systems (e.g., the catecholamines and acetylcholine). Thus, the maturation and senescence of neurotransmitter systems have direct implications for lifespan development. In addition to reviewing evidence on life age differences in dopaminergic modulation

and cognitive development, this brief review selectively highlights recent findings on how important influences from the developm編輯ental context, such as reward-mediated motivational processes, transgenerational stress transmission, psychosocial stress, and cognitive interventions, may, in part, exert their effects on brain and behavioral development through their effects on neuromodulatory mechanisms.

Dr. Barbara Wilson 演講 – 03/05 (三) 12:30 心理 N100

[2014/02/27] 講題:Comprehensive Holistic Rehabilitation for people with non-progressive brain injury: The Oliver Zangwill Center Approach

外賓:Dr. Barbara Wilson (Founder of the Oliver Zangwill Center, Honorary Consultant Psychologist)

時間:2014/03/05, 12:30 am

地點:心理 N100

摘要:Concerned with the amelioration of cognitive, emotional, psychosocial and behavioural deficits caused by an insult to the brain. NR is one of many fields needing a broad theoretical base incorporating frameworks, theories and models from many different areas. Being constrained by one theoretical model can lead to poor clinical practice. The starting point for any rehabilitation programme is the patient and his or her family. In addition to background and ethnic and social issues, the nature, extent, and severity of brain damage should be determined. Current problems, including cognitive, emotional, psychosocial, and behavioural, need to be assessed. Behavioural or functional assessments can be used to complement standardised assessment procedures. Having identified problems, the rehabilitation programme can be planned. Patients, families and staff need to negotiate meaningful, functionally relevant and attainable goals. There is plenty of evidence to show that neuropsychological rehabilitation is clinically effective. Cicerone and his colleagues, for example, in a meta-analysis, found that such programmes can improve community integration, functional independence, and productivity, even for patients who are many years post injury (Cicerone et al 2011). Van Heughten et al 2012) looked at 95 randomised control trials carried out between 1980 and 2010 and concluded that there is a large body of evidence to support the efficacy of cognitive rehabilitation

The Oliver Zangwill Centre for Neuropsychological Rehabilitation opened in 1996 following three years of negotiations between the Medical Research Council (MRC) and the local National Health Service (NHS) Trust. The centre is probably unique in that it is a partnership between a health care provider, the NHS, and a research funding body, the MRC. The Centre aims to provide an excellent clinical rehabilitation service influenced by and contributing to research into the rehabilitation of survivors of brain injury. We 1) provide a therapeutic milieu, 2) make certain that the goals set for clients are meaningful and functionally relevant, 3) ensure shared understanding between staff, clients and families, 4) apply psychological interventions to the cognitive, emotional and psychosocial difficulties encountered by the clients, 5) manage cognitive impairments through compensatory strategies and retraining of skills and, 6) work closely with families and carers. Patients are between 16- 60 years old, with non-progressive brain injuries and living with cognitive, emotional and psychosocial problems. Treatment is offered for six months. For the first six weeks patients attend four days a week from 10 in the morning until four in the afternoon. This is the intensive phase. For the second twelve weeks, the integration phase, patients attend two days a week. For the rest of the week they are reintegrating into work or higher education or else they are leaning to be more independent. Therapy involves both group and individual therapy which addresses their cognitive, emotional and psychosocial needs. This is centered around goal attainment. One survey showed that most patients achieved the goals set. Although the treatment follows a holistic (otherwise known as an intensive or milieu oriented approach) it is heavily influenced by a number of theories, models and frameworks.

Symposium on Medical Genetics and Genomics : 02/25(二)13/30 基醫202



Symposium on Medical Genetics and Genomics

Feb. 25, (TUE) 2014

Room 202, Basic Medical Science Building, NTU College of Medicine

Time Agenda
1:30-1:40 pm Opening Remarks

Hong-Nerng Ho, Associate Dean, NTU College of Medicine

Mark S. Wrighton, Chancellor, Washington University in St. Louis

Larry J. Shapiro, Dean, Washington University School of Medicine


1:40-2:10 pm “Plasma and Image Biomarkers of Alzheimer’s Disease"

Ming-Jang Chiu, PhD(邱銘章副教授)

Associate Professor

National Taiwan University College of Medicine

2:10-2:40 pm “New Approaches to the Treatment of Alzheimer’s Disease"

Larry J. Shapiro, MD
Spencer T. and Ann W. Olin Distinguished Professor

Executive Vice Chancellor for medical Affairs and Dean

Washington University School of Medicine


2:40-3:00 pm Breaks


3:00-3:30 pm “Current Research at NTUCM"

Shu-Chun Teng, PhD(鄧述諄教授)

Professor and Associate Dean

National Taiwan University College of Medicine


“Translational Medicine in NTUGCM: From Genomics to Proteomics “

Szu-Hua Pan, PhD(潘思樺助理教授)

Assistant Professor

National Taiwan University College of Medicine

3:30-4:00 pm “Recent Advances in Cancer Genomics"

Richard K. Wilson, PhD

Alan A. and Edith L. Wolff Distinguished Professor and Director
The Genome Institute, Washington University School of Medicine


4:00-4:30 pm Collaborative Discussion (lead by Associate Dean Teng, NTUCM)



« Older Entries